51.63
price up icon0.19%   0.10
after-market Handel nachbörslich: 52.00 0.37 +0.72%
loading

Finanzdaten der Viking Therapeutics Inc-Aktie (VKTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
16.35%
34.07
29.29 27.27 23.74 20.54
Operating Income/Loss
16.35%
-34.07
-29.29 -27.27 -23.74 -20.54
Income/Loss From Continuing Operations Before Tax
11.19%
-27.36
-24.60 -22.53 -19.23 -19.53
Income/Loss From Continuing Operations After Tax
11.18%
-27.36
-24.61 -22.53 -19.23 -19.53
Net Income/Loss
11.18%
-27.36
-24.61 -22.53 -19.23 -19.53
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,444%
103.46
1.866 99.85 99.01 78.35
Diluted Average Shares
5,444%
103.46
1.866 99.85 99.01 78.35
Basic Earnings Per Share
4.00%
-0.26
-0.25 -0.23 -0.19 -0.25
Diluted Earnings Per Share
4.00%
-0.26
-0.25 -0.23 -0.19 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Kapitalisierung:     |  Volumen (24h):